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Abstract 
Streptococcus pneumoniae represents an important human bacterial pathogen, and the increase in 
antibiotic resistance demands the development of new antimicrobial compounds. Several reports 
have suggested that yeast killer toxins show activity against bacteria and we therefore investigated 
the activity of K9 killer toxin from the yeast Williopsis saturnus var. mrakii NCYC 500 against S. 
pneumoniae. However, no inhibition of bacterial growth was observed with concentrated K9 
preparations in agar diffusion assays and in liquid culture. Although cell morphology was slightly 
affected by K9 treatment, no effect on cellular viability was detectable, and K9 had no stimulatory 
effect on cell lysis induced by beta-lactams or TritonX100. This indicated that K9 did not 
contribute to cell wall damage. Moreover, flow cytometry was used as a sensitive assessment of 
integrity of cells exposed to killer toxin. No significant damage of S. pneumoniae cells was evident, 
although minor changes in fluorescence suggested that K9 killer toxin may interact with bacterial 
surface components.  
 
Introduction 
The increase of drug-resistant bacterial strains represents a major global medical challenge. 
Antibiotic therapy is becoming ineffective against a significant number of nosocomial infections 
and there is therefore a pressing need to identify and characterize new antibacterial agents. 
Although the antimicrobial effects of antibiotics, bacteriophages and bacteriocins have been known 
for a long time, the antimicrobial activity of yeast-derived metabolites has been demonstrated only 
relatively recently (Bevan and Makover 1963).  
 Killer yeasts secrete proteinaceous toxins that have potential in medicine and 
biotechnology (Schmitt and Breinig 2002). They have potential in the biocontrol of contaminant 
microbes in fermentation processes (Palpacelli et al. 1991), and for intraspecific characterization of 
industrially and clinically interesting yeast cultures (Buzzini and Martini 2000). The use of 
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selected toxins as antimycotic agents against pathogenic yeasts that cause systemic mycoses has 
also been suggested (Hodgson et al. 1995; Walker et al. 1995). Very little is known about the 
antibacterial mode of action of killer yeasts. Most killer toxins are small secreted peptides below 
20 kDa, but some Williopsis strains secrete active compounds of much larger size (85 kDa) 
(Guyard et al. 2002). Previous research has shown that killer toxins of Hansenula anomala, 
Hansenula (Williopsis) mrakii, Kluyveromyces drosophylarum, Kluyveromyces lactis and Candida 
tropicalis have potential growth inhibitory activity against Gram-positive pathogenic and 
nonpathogenic bacteria (Polonelli and Morace 1986; Izgü and Altinbay 1997). However, in these 
studies only growth inhibition zones of bacteria on agar plates surrounding the growth of yeast 
strains was recorded, and the toxic activity of yeast metabolic compounds rather than killer toxin 
could not be excluded. In the present paper, we reassessed the activity of yeast killer toxin on a 
Gram-positive bacterium using flow cytometry. This technique is a useful method for determining 
antimicrobial effects, and has been used for studies in bacteria for many years (Boye et al. 1983). It 
has also been used to assess influence of antifungal agents against yeast using the membrane 
integrity fluorescent dye, propidium iodide (Green et al. 1994). Our attention was drawn to the 
killer toxin of Hansenula (Williopsis) mrakii K9, because it is stable at high temperatures (100°C, 
for 10 min) and retains activity over a wide range of pH values (pH 2 to 11) (Yamamoto et al. 
1988; Buzzini et al. 2004). We chose Streptococcus pneumoniae as test organism since it is a 
major human pathogen and the recent emergence of drug resistance in this species worldwide 
exemplifies the need for new antibacterial compounds (Brussow and Desiere 2001; Henriques-
Normark 2007).  
 4 
Materials and methods 
Microbial strains and media  
The K9 killer toxin producer yeast strains Williopsis saturnus var. mrakii NCYC 2251, NCYC 500, 
and killer toxin sensitive Saccharomyces cerevisiae NCYC 1006 were obtained from the yeast 
collection of Abertay University of Dundee. Yeast cells were grown in Yeast Medium (YM) (0.3% 
yeast extract, 0.3% malt extract, 0.5% peptone, 1% glucose) broth or on YM agar plates (YM broth 
with 1% agar). For preparation of crude K9 killer toxin, Williopsis saturnus var. mrakii was grown 
in Edinburgh Minimal Medium 3 (EMM3) (Creanor and Toyne 1993). Cells used for K9 activity 
assays were grown in YM or EMM3 medium for 72 h at 28°C.  
E. coli NCIMB 10000 (previously named ML30) has been described Cohn and Horibata (1959), 
was grown in Brain Heart Infusion (BHI) broth aerobically, or on BHI agar (1 % agar) plates. 
Streptococcus pneumoniae R6 - an un-encapsulated derivate of the Rockefeller University strain 
R36A (Avery et al. 1944) and the highly virulent strains S. pneumoniae TIGR4 previously named 
JNR 7/87 contains a type 4 capsule (Bricker and Camilli 1999) were grown in Brain-Heart-
Infusion (BHI) broth or in the semi-synthetic C-medium supplemented with 0.1% yeast extract 
(Difco) at 37°C without aeration (Lacks and Hotchkiss 1960). As solid medium, D-agar (Alloing et 
al. 1996) supplemented with 3 % defibrinated sheep blood (Oxoid, Wesel, Germany) were used. 
Other Gram-positive bacteria (Staphylococcus aureus, Bacillus subtilis) were grown in Luria 
Bertani (LB) medium. Growth of S. pneumoniae was followed with Nephelometry (Nephelometer 
Units = N) or by determination of OD660 (Ultrospec 110pro, Amersham Biosciences). 
 
Preparation of crude K9 killer toxin 
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Williopsis saturnus var. mrakii NCYC 500 was grown in 10 l EMM3 broth (pH 4.5) for 48 h at 
room temperature (20°C). Cells were harvested by continuous centrifugation (Heraeus, Japan) at 
1000 x g and the supernatant containing the crude killer toxin was filtered and concentrated 25fold 
using a 10 kDa cut-off membrane filter system (Millipore, Japan) in order to remove acid and other 
metabolic products with potential antimicrobial activity. This preparation was used for flow 
cytometric analyses. Using an Amicon Ultracel_10 regenerated cellulose 10 kDa cut of membrane 
filter, an approximately 250fold concentrated K9 toxin preparation was obtained which was used 
for testing antibacterial activity during bacterial growth in liquid medium. Protein concentration of 
crude toxin preparations was determined using a Coomassie (Bradford) protein assay kit (Pierce, 
Rockford. IL).   
 
Agar diffusion assay for killer yeast activity  
Bacteria were diluted in 20 ml agar medium favorable for bacterial growth (as described above)  at 
ca. 1 x 106 CFU before distribution into Petri dishes; alternatively cells were plated on the agar 
surface. No differences concerning K9 activity were observed between these two procedures. After 
solidification of the agar, the surface was spotted with live cells of killer-yeast, sensitive yeast, 
crude K9 killer toxin and yeast growth medium (20 µl each). The plates were incubated at 37°C for 
24 h. As positive control for K9 activity, the sensitive yeast strain Saccharomyces cerevisiae 
NCYC 1006 was used grown in buffered YM agar plates (pH 4.5) or non buffered YM agar 
(pH7.0) and the plates incubated at 28°C for 24 h.  
 
Effect of K9 killer toxin on S. pneumoniae cells grown in liquid media  
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In addition to the agar diffusion assays described above, the activity of crude K9 preparations 
against S. pneumoniae in liquid media was also tested, as follows. 
S. pneumoniae R6 and TIGR4 were grown in C-Medium or BHI broth and allowed to grow at 35°C 
until reaching a cell density of N = 15 (30) and divided into several aliquots. Samples of 
concentrated K9 toxin (final concentration1 µg/ml) and/or benzylpenicillin (1 µg/ml final 
concentration) or EMM medium (as negative control) were added, and growth followed at 30 min 
intervals by nephelometry (N). Untreated growing cultures of S. pneumoniae were used as positive 
controls. 
 
Flow cytometric assay of yeast killer toxin activity 
Bacterial growth in liquid media was monitored at regular intervals using a Novospec II 
(Pharmacia) photometer. Culture samples were taken at three different time points during growth, 
and stained with propidium iodide (PI; Invitrogen, USA). At the same time, cells were examined 
microscopically. After washing with saline (0.9 % NaCl) (3x), cells were diluted in saline to a final 
OD600 = 0.1 prior to addition of K9 toxin or antibiotic. Fluorescence measurements were made with 
a FloMax flow cytometer (Partec, Germany) using 532nm excitation and emission at 570 to 
610nm. 
 
Results and Discussion 
Activity of K9 killer toxin on cells grown on agar plates 
Williopsis saturnus var. mrakii NCYC 500 was grown in minimal medium for 24 hours, and a 
crude concentrated preparation of the growth medium was used for testing the activity of the K9 
killer toxin. It has previously been suggested (Polonelli and Morace 1986) that activity of yeast 
toxins against Gram-negative as well as Gram-positive bacteria may be due to acid or other 
metabolic products in the preparations obtained from citrate-buffered medium which are generally 
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inhibitory to bacteria (Izgü and Altinbay 1997). Therefore, YM (which does not contain citrate) 
was used for growth of yeast cells in all experiments conducted.  
In order to assess antimicrobial activity of the K9 toxin, live cells of Saccharomyces 
cerevisiae NCYC 1006 served as a sensitive control culture. Toxin-sensitive cells were grown on 
agar plates, and K9 preparations were spotted onto the agar surface. The K9 preparation as well as 
both live cells of W. saturnus var. mrakii strains showed clear activity against the sensitive yeast 
strain S cerevisiae NCYC1006 (Fig. 1A). No activity of yeast cells or concentrated K9 was 
observed with both S. pneumoniae indicator strains, the virulent serotype 4 strain TIGR4, and the 
un-encapsulated laboratory strain R6 (Fig. 1B). Occasionally, faint inhibitory zones were visible, 
but these effects may not be attributable to yeast killer toxin as other media-derived components 
may inhibit bacterial cells. The same negative results were obtained using other Gram-positive 
bacteria such as Staphylococcus aureus and Bacillus subtilis (not shown). 
 
Effect of K9 killer toxin on cells grown in liquid culture  
The activity of crude K9 preparations against S. pneumoniae was tested in two liquid media as a 
more subtle assay of bacterial growth inhibition compared with agar diffusion. These media do not 
contain blood, which could affect killer toxin activity, and all undefined ingredients are similar to 
those in yeast medium which have no effect on killer toxin activity. Nevertheless, no effect on 
generation time and stationary phase cell lysis was observed with K9 in both, S. pneumoniae R6 
and TIGR4 cultures, independent of the choice of growth medium (see Fig. 2A and B for 
examples), and viability was also unaffected when compared to the untreated control cultures (not 
shown). However, morphology of the S. pneumoniae cells was slightly affected after 2 hours of K9 
treatment with the appearance of aberrant cells (Fig. 3A and B).  
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Effect of K9 toxin on cellular lysis induced by beta-lactams and Triton X100 
As there was some indication of minor cellular damage to bacteria due to K9 treatment, we 
assumed that lysis induced by other cell envelope damaging agents may augmented synergistically 
with yeast killer toxin. S. pneumoniae is highly susceptible to lysis induced by penicillins and 
detergents, thus benzylpenicillin (1 µg/ml) and Triton X100 (0.001 %) was used with and without 
additional K9 treatment. No significant difference in the rate of lysis was observed, either if K9 and 
benzylpenicillin were added simultaneously, or if cells were pretreated with K9 for 20 min before 
the addition of the lytic compound. Fig. 4 shows the results obtained with benzylpenicillin; similar 
results were obtained with Triton X100 (not shown).     
 
Flow cytometry analysis  
Flow cytometric analyses were performed in order to detect subtle changes induced by K9 
treatment to S. pneumoniae cells. S. pneumoniae R6 cultures were grown in liquid medium and 
treated with K9 killer toxin. In addition, R6 cells were treated with a lytic beta-lactam antibiotic for 
comparison. Growth was measured and flow cytometric analysis performed immediately before 
treatment, 4h after treatment and from cultures exposed to killer toxin (Fig. 5B). E. coli 
NCIMB10000 (Fig. 5 C) and Saccharomyces cerevisiae NCYC1006 (Fig. 5A) were used as a 
negative and positive control, respectively.  
 Sensitive yeast cells clearly showed intense fluorescence of the entire population (Fig. 5A), 
whereas no effect was seen with E. coli (Fig. 5C). S. pneumoniae when treated with crude K9 killer 
toxin showed a slightly enhanced PI staining, indicating some changes as a result of K9 activity. 
The K9 effect, however, was significantly less when compared to penicillin treatment (Fig. 5B). 
Changes were more pronounced after overnight treatment. In contrast, treatment with the beta-
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lactam resulted in increased PI staining of the bacterial cells documenting massive cell damage 
(Fig. 5B).   
 
Conclusions 
We could not detect anti-Streptococcal activity of K9 toxin produced by Williopsis saturnus var. 
mrakii NCYC 500, that has been observed with other yeast strains where only growth inhibition on 
agar plates has been recorded (Polonelli and Morace 1986; Izgü and Altinbay 1997). Growth of S. 
pneumoniae, either on agar plates or in liquid media, was virtually unaffected by exposure to K9. 
Additionally, no effect of K9 was observed on stationary phase lysis typical for S. pneumoniae 
grown in liquid medium, and K9 did not enhance bacterial cell lysis triggered by beta-lactams or 
the detergent Triton X100. However, we could not exclude some form of molecular interaction of 
the yeast toxin with S. pneumoniae cells since slight alterations of cell morphology, as well as a 
slight shift in PI fluorescence staining using flow cytometry of K9 treated pneumococci were 
observed. Electron microscopy of yeast killer toxin treated bacteria may provide some insight 
regarding cell wall damage, as has been reported for yeast cells (Vadasz et al. 2000).  For bacteria, 
biochemical analyses of cell wall composition and cell wall associated proteins may additionally 
provide information on yeast toxin induced cell wall associated changes. In this context it is 
interesting that monoclonal antibodies representing the internal image of another yeast killer toxin 
produced by a Pichia anomala ATCC96603 have been shown to exert activity against a wide 
spectrum of Gram-positive bacteria including S. pneumoniae by an unknown mechanism, but most 
likely via interaction with cell surface polysaccharides (Conti et al. 2000; Conti et al. 2002). The 
binding of yeast killer toxins to bacterial surface components represents an interesting basis which 
could be exploited for the development of antibacterial compounds. Further biochemical 
characterization of antibacterial yeast killer toxins are required, together with understanding of their 
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molecular interaction with specific cell surface binding sites on bacteria in order to evaluate their 
potential as novel therapeutic agents.   
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Figure Legends 
Figure 1. Activity of yeast killer toxin on yeast and S. pneumoniae cells. (A) The indicator strain 
Saccharomyces cerevisiae NCYC1006 was grown on YM agar plates. 1, S. cerevisiae NCYC1006; 
2, Williopsis saturnus var. mrakii NCYC500; 3, EMM3 Medium. (B) S. pneumonia TIGR4 was 
grown on blood agar plates. Samples: 1, 250fold concentrated medium of Williopsis saturnus var. 
mrakii NCYC500; 2, 250fold concentrated killer K9 toxin; 3, EMM3 Medium (20 µl).  
 
Figure 2. Activity of K9 toxin on S. pneumoniae in liquid culture. 
S. pneumoniae R6 (A) and TIGR4 (B) were grown in BHI and allowed to grow at 35°C until 
reaching a cell density of N = 30. At the time indicated, concentrated K9 toxin (■ 1 µg/ml), EMM 
medium (▲) or benzylpenicillin (1 µg/ml final concentration) was added, and growth followed by 
nephelometry (N). ●: untreated control. 
 
Figure 3. Effect of K9 toxin on S. pneumonia morphology. Exponentially growing S. pneumoniae 
R6 (A, B) and TIGR4 (C, D) in BHI medium were treated with a concentrated K9 toxin preparation 
at N = 30 for 60 min (B, D). Pictures were taken with a Nikon Eclipse E600 microscope in phase 
contrast. 
  
Figure 4. Effect of K9 toxin on benzylpenicillin induced lysis. An exponentially growing 
culture of S. pneumoniae R6 in BHI was divided into seven aliquots at N = 15 (t = 0), and 
treated with benzylpenicillin (1 µg/ml) and/or K9 toxin (solid arrow); the open arrow 
indicates time of addition of benzylpenicillin at 20 min. Growth was monitored throughout 
the experiment by Nephelometry. ●: untreated control; ▲K9 toxin; □ benzylpenicillin; ○ 
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K9 plus benzylpenicillin;  ∆ K9 followed by benzylpenicillin at 20 min; ♦ benzylpenicillin 
at 20 min.  
 
Figure 5. Flow cytometry analysis of K9 killer toxin activity on yeast and bacterial cells. As 
controls, S. pneumoniae R6 was also treated with benzylpenicillin (1 µg/ml), and E. coli with 
ampicillin (1 µg/ml); cells killed by incubation at 100°C for 60 min were also used. Samples were 
taken before the addition of K9 toxin or the antibiotic, after 4 h and after overnight treatment, and 
prepared for flow cytometry as described in Materials and Methods. A: susceptible Saccharomyces 
cerevisiae NCYC1006; B: S. pneumonia R6 grown in BHI; C: E. coli NCIMB 10000 grown in BHI 
medium. Compounds were added to bacterial cultures at OD600 = 0.3. 
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Figure 2 Oshigawa et al.time [min]
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Figure 3 Oshigawa et al.
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Figure 5A Oshigawa et al.
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Figure 5B Oshigawa et al.
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